Dofetilide
Active substance: dofetilide
CAPSULE · DOFETILIDE .125 mg/1
United StatesActive
Marketing holder: Bionpharma Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DOFETILIDE · .125 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2ae7-7b08-b679-f4be0a613c49,01a1208c-3070-766d-a7ee-0684ef4e699f,01a1208c-45d1-7eb0-bfa5-8f44950f7681,01a1208c-5b79-7dc2-a56a-4574fe7a8391,01a1208c-af18-777e-81c9-e57666fed581;count=38 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 69452-131
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 69452-131 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69452-131 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69452-131 · Verified 2026-10-09 · open in source